Federal News & Issues

WASHINGTON, D.C., March 1, 2021 – Diversity, equity and inclusion (DEI) leaders in academic medicine are subject to increasing expectations with limited resources and there is an urgent need for psychiatry departments to commit to fully supporting their efforts, according to an article now available in the American Journal of Psychiatry written by top DEI leaders in academic psychiatry from across the country.

The authors, representing prominent public and private institutions, include Ayana Jordan, M.D., Ph.D., Yale University, and current APA ECP Trustee-at-Large; Ruth S. Shim, M.D., M.P.H. University of California, Davis; Carolyn I. Rodriguez, M.D., Ph.D., Stanford University; Eraka Bath, M.D., University of California, Los Angeles; Jean-Marie Alves-Bradford, M.D., Columbia University; Lisa Eyler, Ph.D., University of...

WASHINGTON, D.C., February 18, 2021 – As the COVID-19 vaccine is being administered across the country, the American Psychiatric Association called on state public health authorities today to include people with serious mental illness (SMI) and substance use disorders (SUD) to the equivalent of Centers for Disease Control and Prevention’s (CDC) Phase 1-C of their prioritization schedules. The recommendation coincides with APA’s recently released guidance document, The Role of the Psychiatrist in the Equitable Distribution of the COVID-19 Vaccine.

Phase 1-C, as defined by the CDC includes people who are 65-74 years old, essential workers, and anyone between ages 16-64 with high-...